Quantcast
Last updated on April 17, 2014 at 21:23 EDT

Latest Dementia with Lewy bodies Stories

2010-05-11 09:00:00

NEW YORK, May 11 /PRNewswire-USNewswire/ -- The Alzheimer's Drug Discovery Foundation (ADDF) and the Lewy Body Dementia Association (LBDA) announced today the recipient of their first partnership research award through the Lewy Body Dementia Biomarker Research Program. The goal of the program is to catalyze the discovery of innovative biomarkers that aid in early diagnosis, detection and disease monitoring of Lewy body dementias (LBD). The ADDF/LBDA program awarded $125,000 to one...

2009-12-15 13:00:00

NEW YORK, Dec. 15 /PRNewswire-USNewswire/ -- The Michael J. Fox Foundation announced $1.7 million in funding to drive new and continuing Parkinson's research projects at the Banner Sun Health Research Institute and Mayo Clinic Arizona, sites of the Arizona Parkinson's Disease Consortium. Of the total funding, $1.1 million represents renewed funding for directed projects led by principal investigators Charles Adler, MD, PhD, at Mayo Clinic Arizona and Thomas Beach, MD, PhD, at Banner Sun...

2009-10-13 10:47:19

Both genetic and pathologic data indicate a role for the neuronal protein alpha-synuclein in Parkinson disease. Previous studies have indicated that phosphorylation of alpha-synuclein at amino acid 129 (Ser129) is a key event in alpha-synuclein"“mediated nerve cell toxicity. However, Mel Feany and colleagues, at Brigham and Women's Hospital, Boston, have now identified a counterbalancing role in nerve cell protection for phosphorylation of alpha-synuclein amino acid 125 (Tyr125). In the...

951edd3b13741f30cce2b5daff36f2cb
2009-10-01 12:50:39

A report on Thursday over the ethical dilemmas of dementia said that millions of people suffering with the brain-wasting disease are often left without care or support until their illness reaches a crisis point, Reuters reported. The British medical ethics group that authored the report criticized health authorities for failing to take a broader view of dementia and called for more focus on easing the daily problems it poses for sufferers and their caregivers. An estimated 35 million people...

2008-08-27 18:00:56

CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease. The researchers have genetically produced the first ever mouse model with the type of brain degeneration, or nerve cell loss, seen in Lewy body disease and Parkinson's disease, which could lead to more targeted drugs...

2008-08-17 18:00:12

By KELLY SHORROCK Dementia patients have welcomed the news that drugs which could slow or prevent the onset of the condition could be available in as little as eight years' time. Scientists at the University of Nottingham have managed to produce a mouse which has the same type of brain degeneration seen in Lewy body disease - a condition which shares characteristics with Alzheim-er's and Parkinson's disease. It is hoped that studying the mouse will help scientists understand more about...

2007-08-23 03:19:55

By Mrak, Robert E Griffin, W Sue T Abstract Cortical Lewy body disease as a cause of dementia has been recognized for more than 40 years. Only in the past 15 to 20 years, however, has the true frequency of this entity come to be appreciated, primarily because of the advent of sensitive and specific immunohistochemical diagnostic techniques. We now know that there is frequent and extensive overlap, both clinically and pathologically, between Lewy body and Alzheimer diseases. Although some of...

2006-02-01 13:16:08

By Michelle Rizzo NEW YORK (Reuters Health) - Brain lesions known as neurofibrillary tangles, such as those seen in Alzheimer's disease, are also associated with impaired gait in older subjects with or without dementia, according to a postmortem study. "The more tangles an older person had in the substantia nigra" - an area of the brain associated with Parkinson's disease -- "the more problems there were with gait," lead author Dr. Julie A. Schneider told Reuters Health. Results...

2005-06-20 15:55:11

TORONTO, Canada - German scientists developed a computer program that enhances the diagnostic accuracy of positron emission tomography (PET) scans with Alzheimer's patients, opening the door for earlier treatment of this progressive brain disorder. Details of their findings were provided at the Society of Nuclear Medicine's 52nd Annual Meeting in Toronto. "Positron emission tomography (PET) with FDG (fluorodeoxyglucose) in the hands of the experienced investigator is the most reliable...

2005-06-15 18:08:45

San Diego, Calif. "“ Researchers at the University of California, San Diego (UCSD) School of Medicine working with scientists at Elan Pharmaceuticals, have reported promising results in mice of a vaccine approach to treating Parkinson's and similar diseases. These results appear in the June edition of the journal Neuron. Eliezer Masliah, M.D., Professor of Neurosciences and Pathology at UCSD, and colleagues at UCSD and Elan Pharmaceuticals in San Francisco, vaccinated mice using a a...